Caricamento...
Molecular Aggregation of Marketed Recombinant FVIII Products: Biochemical Evidence and Functional Effects
Background Recombinant (rec-) coagulation factor VIII concentrates available for hemophilia A (HA) treatment differ in cell line production and structure, which could affect their pharmacodynamics and immunogenicity. Clinical trials showed that previously untreated patients with severe HA present h...
Salvato in:
| Pubblicato in: | TH Open |
|---|---|
| Autori principali: | , , , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Georg Thieme Verlag KG
2019
|
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6524925/ https://ncbi.nlm.nih.gov/pubmed/31249992 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1055/s-0039-1688413 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|